Uploaded December 2024 | Updated November 2026, 3 hours ago
To kick off the 2024 Rare Neuroimmune Disorders Symposium (RNDS), we heard from SRNA's President, Sandy Siegel and SRNA Board Member, Dr. Benjamin Greenberg of the University of Texas Southwestern Medical Center.
To kick off the 2024 Rare Neuroimmune Disorders Symposium (RNDS), we heard from SRNA's President, Sandy Siegel and SRNA Board Member, Dr. Benjamin Greenberg of the University of Texas Southwestern Medical Center.
![2026 RNDS | Pediatric Case Series in Anti-Aquaporin-4 Antibody-Positive NMOSD
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Darina Dinov, DO, of Penn State University, spoke about pediatric neuromyelitis optica spectrum disorder (NMOSD) and how children have tolerated the treatment inebilizumab [00:00:05]. She compared pediatric and adult NMOSD, including the lack of FDA-approved medications for children and what off-label use can mean for insurance approval [00:01:40]. She explained the role of aquaporin-4 and B cells, and how inebilizumab reaches more of the cells that lead to antibody production than rituximab does [00:05:20]. Dr. Dinov presented a retrospective case series of four children, ages seven to 17, treated at UT Southwestern and Childrens Dallas, all of whom tolerated their infusions [00:10:54]. She closed with what the findings may mean for families and clinicians seeking insurance approval, and the two ongoing pediatric trials [00:18:25].
Darina Dinov, DO, is a neurologist at Penn State University specializing in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and the blood vessels that relate to these structures. She is passionate about advancing our understanding through research, education, and innovation, and her work focuses on interdisciplinary approaches to solving complex problems and contributing to the scientific community.
00:00 Introduction
01:01 What Is NMOSD
01:40 Pediatric and Adult Similarities
03:17 No Approved Medications for Children
05:20 Aquaporin-4 and the Immune System
08:25 How Inebilizumab Works
10:54 The Four-Child Case Series
15:42 Results and Tolerability
16:52 Why Inebilizumab Matters
18:25 What This Means for Families and Clinicians
20:13 Ongoing Pediatric Trials and Thanks 2026 RNDS | Pediatric Case Series in Anti-Aquaporin-4 Antibody-Positive NMOSD](https://i.ytimg.com/vi/JuoCbOXEPLw/mqdefault.jpg)




![2026 RNDS | Q-Cell Study Updates
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Benjamin Greenberg, MD, MHS, of the University of Texas Southwestern gave an update on the Q-Cell stem cell study in myelitis [00:00:06]. He explained how stem cells could repair myelin in the spinal cord, along with the risks that took years of animal studies to address, including cells forming something unwanted and the body rejecting them [00:00:59]. He warned about unregulated stem cell clinics and described why Q-Cells were chosen and how a floating cannula delivers them into the spinal cord [00:06:44]. Dr. Greenberg reviewed who can take part, the safety findings so far in the people who have had the procedure, and how to sign up through the SRNA website [00:15:37]. He ended with thanks to donors, the surgical team, and participants, then took audience questions about next steps, including enrolling people with recurrences and treating the neck [00:21:17].
Benjamin Greenberg, MD, MHS, received his Bachelor of Arts degree from Johns Hopkins University and his Masters degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health. He attended medical school at Baylor College of Medicine, completed his neurology residency at The Johns Hopkins Hospital, and joined the Hopkins faculty in neuroimmunology, where he became Co-Director of the Transverse Myelitis Center and Director of the Encephalitis Center. In 2009, he was recruited to the University of Texas Southwestern Medical Center as Director of the new Transverse Myelitis and Neuromyelitis Optica Program, and that same year he established the Pediatric Demyelinating Disease Program at Childrens Medical Center Dallas.
He now serves as Director of the Perot Foundation Neurosciences Translational Research Center within the ODonnell Brain Institute and Vice Chair of Translational Research for the Department of Neurology. Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system.
00:00 Welcome and Introduction
00:39 Disclosures
00:59 The Promise of Stem Cells
03:27 Risks of Stem Cell Transplants
06:44 Unregulated Stem Cell Clinics
08:43 Why Q-Cells Were Chosen
11:22 Getting Cells to the Spinal Cord
15:37 Who Can Take Part
18:16 Safety Results So Far
19:51 How to Sign Up and Next Steps
21:17 Acknowledgements
23:17 Questions from the Audience 2026 RNDS | Q-Cell Study Updates](https://i.ytimg.com/vi/MIjzBjwwpoc/mqdefault.jpg)
![2026 RNDS | Spasticity Management and Mobility
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Philippines Cabahug, MD, of the Kennedy Krieger Institute, spoke about spasticity management and mobility [00:01:09]. She defined spasticity as involuntary muscle tightness or spasms that increase when a muscle is stretched quickly, showed clonus and spasms, and explained that when disease affects the brain and spinal cord the reflex arc loses its normal control [00:02:17]. Dr. Cabahug described how spasticity affects pain, movement, hygiene, and sleep, and why a change from a persons usual baseline can act as an early warning sign, with common triggers including bladder, bowel, skin, clothing, and temperature [00:06:27]. She reviewed the steps of management, from addressing triggers and daily slow stretching to standing, splints, physical and occupational therapy, aquatic therapy, medications, Botox injections, an intrathecal baclofen pump, and surgery [00:11:51]. She closed with an action plan and guidance for women of childbearing age on baclofen [00:17:07].
Philippines Cabahug, MD, earned her B.S. in physical therapy at the University of the Philippines in 1994 and her medical degree at St. Lukes-WHQ Memorial, Philippines, in 2000. She completed a physical medicine and rehabilitation (PM&R) residency at the Philippine General Hospital in 2005, a second PM&R residency at Johns Hopkins Hospital in 2012, and a fellowship in spinal cord injury (SCI) medicine at Johns Hopkins Hospital and the Kennedy Krieger Institute in 2013. She practices at the International Center for Spinal Cord Injury at the Kennedy Krieger Institute, where she is director of Musculoskeletal Ultrasound and runs a musculoskeletal diagnostic clinic and an ultrasound-guided intrathecal pump access clinic. She is board certified in PM&R and in spinal cord injury medicine and is a faculty clinical instructor with the Department of Physical Medicine and Rehabilitation at the Johns Hopkins School of Medicine.
00:00 Introduction to Dr. Cabahug
01:09 Welcome and Session Goals
02:17 What Spasticity Is
03:03 Clonus, Reflexes, and Spasms
04:15 Who Is Affected
05:15 Why Spasticity Happens
06:27 Effects on Daily Life
08:30 Triggers to Check For
10:07 Evaluation and Treatment Goals
11:51 Management Options
13:07 Stretching and Therapy at Home
15:43 Medications and Referral
17:07 Action Plan and Care Points 2026 RNDS | Spasticity Management and Mobility](https://i.ytimg.com/vi/MJjT_7wkIZc/mqdefault.jpg)

![1203. Community Spotlight | Rick Telander
The “Community Spotlight” edition of the “Ask the Expert” podcast series shares the stories of our community members. For this episode, Rick Telander joined Dr. GG deFiebre of SRNA to talk about his journey with transverse myelitis (TM). Rick shared about his diagnostic process [00:08:05], the testing that took place, and the treatment and rehabilitation that he received [00:09:25]. He emphasized the importance of early diagnosis, research for better treatments, and support from organizations like SRNA [00:25:02]. Rick also discussed ongoing symptoms, his experience of living with TM, and the childrens book of poetry that he published [00:26:11].
Rick Telander is the Senior Sports Columnist for the Chicago Sun-Times. He is the author of ten books and was previously a senior writer for Sports Illustrated and ESPN, the Magazine. An original member of “The Sportswriters on TV” television show, Rick has been named Illinois Sportswriter of the Year nine times, and his work has been collected in over a dozen anthologies. He has been awarded the Sigma Delta Chi Award by the Society of Professional Journalists and the Dan Jenkins Lifetime Medal for Excellence in Sportswriting from the University of Texas. In 2021 he was inducted into the National Sportswriters Hall of Fame in Winston-Salem, North Carolina. Rick’s book, Sweet Dreams: Poems and Paintings for the Child Abed is available online:
https://www.skyhorsepublishing.com/9781510778337/sweet-dreams/ 1203. Community Spotlight | Rick Telander](https://i.ytimg.com/vi/NFk_-PyV5Hk/mqdefault.jpg)
![Community Meets Clinic 303. Dr. Benjamin Greenberg
The Community Meets Clinic podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode hosted by Krissy Dilger of SRNA, we met Dr. Benjamin Greenberg of the UT Southwestern Medical Center, which has been designated as a Center of Excellence in Rare Neuroimmune Disorders. He outlined research including a
stem cell program and immune-remodeling therapies for NMO aimed at reducing long-term immunosuppression [05:49]. Dr. Greenberg illustrated multidisciplinary care at UT Southwestern and Children’s Medical Center, emphasized options for second opinions and clinician-to-clinician remote consultation, and shared hopes for nervous system repair trials and curative immune therapies [07:18]. You can view Dr. Benjamin Greenbergs medical profile here:
https://utswmed.org/doctors/benjamin-greenberg/
Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children’s Medical Center [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program].
Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago’s Rush Presbyterian-St. Luke’s Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor’s degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation’s first dedicated Transverse Myelitis Center.
Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children’s Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.
00:00 Welcome and Guest Intro
01:41 Path to Neurology
03:50 Why Neuroimmunology
05:49 Research Focus and Trials
07:18 Clinic Team and Referrals
10:31 Self Care and Hobbies
12:17 How the Clinic Can Help
14:16 Hope for Future Therapies
15:56 Wrap Up Community Meets Clinic 303. Dr. Benjamin Greenberg](https://i.ytimg.com/vi/NMl06hvkRHc/mqdefault.jpg)
